Enhancing Glioblastoma Immunotherapy with Integrated Chimeric Antigen Receptor T Cells through the Re-Education of Tumor-Associated Microglia and Macrophages-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhancing Glioblastoma Immunotherapy with Integrated Chimeric Antigen Receptor T Cells through the Re-Education of Tumor-Associated Microglia and Macrophages

Published:2024-04-16 Issue:17 Volume:18 Page:11165-11182
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Zhu Nianci¹²,Chen Sijia¹²,Jin Yu¹²,Wang Meng¹²,Fang Luyao¹²,Xue Lingjing¹²,Hua Dexiang¹²,Zhang Ziyao¹²,Jia Meng³,Hao Meixi¹²,Zhang Can¹²^ORCID

Affiliation:

1. State Key Laboratory of Natural Medicines, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing 211198, China

2. Chongqing Innovation Institute of China Pharmaceutical University, Chongqing 401135, China

3. School of Life Sciences, Nanjing University, Nanjing 210093, China

Funder

Ministry of Education of the People's Republic of China

State Key Laboratory of Natural Medicines

China Pharmaceutical University

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

National Center of Technology Innovation for Biopharmaceuticals

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c00050

Reference66 articles.

1. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015–2019

2. Management of glioblastoma: State of the art and future directions

3. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

4. Current state of immunotherapy for glioblastoma

5. Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric antigen receptor (CAR) T-cell therapy: Harnessing extracellular vesicles for enhanced efficacy;Pharmacological Research;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3